ATE461448T1 - Verfahren zur abschätzung des metabolismus eines arzneistoffs in der menschlichen leber sowie der leberfunktion - Google Patents

Verfahren zur abschätzung des metabolismus eines arzneistoffs in der menschlichen leber sowie der leberfunktion

Info

Publication number
ATE461448T1
ATE461448T1 AT05780351T AT05780351T ATE461448T1 AT E461448 T1 ATE461448 T1 AT E461448T1 AT 05780351 T AT05780351 T AT 05780351T AT 05780351 T AT05780351 T AT 05780351T AT E461448 T1 ATE461448 T1 AT E461448T1
Authority
AT
Austria
Prior art keywords
liver
chimeric animal
human
drug
metabolism
Prior art date
Application number
AT05780351T
Other languages
English (en)
Inventor
Shin-Ichi Ninomiya
Yoshihiro Ohzone
Yasuhisa Adachi
Toru Horie
Yoshinori Soeno
Tae Inoue
Original Assignee
Sekisui Medical Co Ltd
Phoenixbio Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sekisui Medical Co Ltd, Phoenixbio Co Ltd filed Critical Sekisui Medical Co Ltd
Application granted granted Critical
Publication of ATE461448T1 publication Critical patent/ATE461448T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G01N33/5038—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving detection of metabolites per se
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5082—Supracellular entities, e.g. tissue, organisms
    • G01N33/5088—Supracellular entities, e.g. tissue, organisms of vertebrates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
AT05780351T 2004-08-20 2005-08-19 Verfahren zur abschätzung des metabolismus eines arzneistoffs in der menschlichen leber sowie der leberfunktion ATE461448T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004240827 2004-08-20
PCT/JP2005/015148 WO2006019162A1 (ja) 2004-08-20 2005-08-19 薬物のヒトにおける肝代謝及び肝機能を予測する方法

Publications (1)

Publication Number Publication Date
ATE461448T1 true ATE461448T1 (de) 2010-04-15

Family

ID=35907545

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05780351T ATE461448T1 (de) 2004-08-20 2005-08-19 Verfahren zur abschätzung des metabolismus eines arzneistoffs in der menschlichen leber sowie der leberfunktion

Country Status (9)

Country Link
US (1) US20080199847A1 (de)
EP (1) EP1801582B1 (de)
JP (1) JP4854509B2 (de)
KR (1) KR101159573B1 (de)
CN (1) CN101014855A (de)
AT (1) ATE461448T1 (de)
CA (1) CA2577644C (de)
DE (1) DE602005020042D1 (de)
WO (1) WO2006019162A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2587886A1 (en) * 2004-11-16 2006-05-26 Hiroshima Industrial Promotion Organization Method of screening candidate drug
JP2011106846A (ja) * 2009-11-13 2011-06-02 Hamamatsu Univ School Of Medicine 新規ｎｓａｉｄ潰瘍リスク判定方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL106368A0 (en) * 1992-07-24 1993-11-15 Univ Pennsylvania Non-native liver generation in an animal with impaired native liver function,by cell implantation
US6129911A (en) * 1998-07-10 2000-10-10 Rhode Island Hospital, A Lifespan Partner Liver stem cell
KR100873690B1 (ko) * 1999-01-19 2008-12-12 유니버시티 오브 노스캐롤라이나 앳 채플 힐 인간 간 전구세포
US6525242B1 (en) 1999-11-02 2003-02-25 The University Of Connecticut Propagation of human hepatocytes in non-human mammals
US6509514B1 (en) * 2000-03-17 2003-01-21 Kmt Hepatech, Inc. Chimeric animal model susceptible to human hepatitis C virus infection
JP2002045087A (ja) * 2000-05-19 2002-02-12 Japan Science & Technology Corp キメラ動物
US7211404B2 (en) * 2001-06-22 2007-05-01 Stem Cells, Inc. Liver engrafting cells, assays, and uses thereof
CN1642981A (zh) * 2002-03-25 2005-07-20 独立行政法人科学技术振兴机构 识别增殖性人肝细胞的抗体、增殖性人肝细胞和功能性人肝细胞
EP1552740A1 (de) * 2004-01-09 2005-07-13 Institut Pasteur Chimaeres Mausmodell enthaltend humane Hepatocyten - Anwendung zum Screening von Verbindungen

Also Published As

Publication number Publication date
JPWO2006019162A1 (ja) 2008-05-08
CA2577644A1 (en) 2006-02-23
EP1801582A1 (de) 2007-06-27
JP4854509B2 (ja) 2012-01-18
US20080199847A1 (en) 2008-08-21
EP1801582B1 (de) 2010-03-17
CN101014855A (zh) 2007-08-08
EP1801582A4 (de) 2007-12-19
KR101159573B1 (ko) 2012-06-26
DE602005020042D1 (de) 2010-04-29
WO2006019162A1 (ja) 2006-02-23
CA2577644C (en) 2012-11-27
KR20070051277A (ko) 2007-05-17

Similar Documents

Publication Publication Date Title
MX381216B (es) Animales no humanos que tienen una expansion de repeticiones de hexanucleotidos en un locus c9orf72.
DK3864152T3 (da) Fremgangsmåder og sammensætninger til editering af rna'er
TNSN08281A1 (en) Mite composition comprising glycyphagidae and phytoseiid mites, use thereof, method for rearing a phytoseiid predatory mite,rearing system for rearing said phytoseiid predatory mite and methods for biological pest control on a crop
ATE524922T1 (de) System und verfahren zur kamerazählung auf der basis der hauttondetektion
WO2006071107A8 (en) Mite composition, use thereof, method for rearing a phytoseiid predatory mite, rearing system for rearing said phytoseiid predatory mite and methods for biological pest control on a crop
BRPI0410040A (pt) combinações de substáncias ativas que apresentam propriedades nematicidas, inseticidas e fungicidas e sáo baseadas em compostos de trifluorbutenila
UY30140A1 (es) Sulfoximinas de (6-haloalquilpiridin-3-il)alquilo n-sustituidas insecticidas
GB0703672D0 (en) Mite composition, use thereof, method for rearing a mite, rearing system, use of the composition in biological pest control, and method of biological pest
MX358710B (es) Uso combinado de proteínas cry1da y cry1fa para el control de la resistencia de los insectos.
MX387734B (es) Combinaciones de principios activos que comprenden piridiletilbenzamidas y otros principios activos.
EA200701426A1 (ru) Композиция клещей, её применение, способ разведения хищного клеща - фитосейида amblyseius swirskii, система для разведения указанного хищного клеща и способы биологического контроля вредителей в культуре
MX351889B (es) Composiciones y métodos anti-cxcr1.
PH12012501424B1 (en) COMBINED USED OF CRY1Ca AND CRY1Fa PROTEINS FOR INSECT RESISTANCE MANAGEMENT
EP1576117A4 (de) Verfahren zur gewinnung lebensfähiger menschlicher leberzellen, einschliesslich hepatischer stamm-/vorläuferzellen
CA2711240C (en) Liver screening method
PH12013502164B1 (en) Active compound combinations comprising a (thio) carboxamide derivative and an insecticidal or acaricidal or nematicidal compound
ATE480145T1 (de) Verfahren und vorrichtung vom schutz von tabak
CL2007003717A1 (es) Composicion insecticida para semillas o cultivos cosechados; metodo para prevenir danos hechos por un insecto; y metodos para preservar semillas y cultivos cosechados.
EA200900452A1 (ru) Способ повышения врождённой продуктивности растения
MX394999B (es) Animales no humanos que comprenden un locus ttr humanizado y metodos de uso
DK1862158T5 (da) Farmaceutisk sammensætning til behandling af depression og fremgangsmåde til fremstilling deraf
DK2022786T3 (da) Middel mod mund- og klovsyge-virus til dyr, der hører til familien suidae eller får, og fremgangsmåde til forebyggelse eller behandling af mund- og klovsyge hos dyr, der hører til familien suidae eller får
DK1514469T3 (da) Fremgangsmåde til malkning af et dyr og en indretning til dette formål
EP2145013A4 (de) Tumortragende tiermodelle mit expression eines für menschlichen leberkrebs spezifischen antigens und verfahren zur analyse der vorbeugungs- und behandlungswirksamkeit von aus dendritischen zellen gewonnenen immuntherapeutika unter verwendung des obigen
DE602005020042D1 (de) Verfahren zur abschätzung des metabolismus eines arzneistoffs in der menschlichen leber sowie der leberfunktion

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties